[Inflammatory and fibrinolytic activation after coronary artery bypass with extracorporeal circulation]
- PMID: 12116815
[Inflammatory and fibrinolytic activation after coronary artery bypass with extracorporeal circulation]
Abstract
Background: The aim of this study was to determine the course of the main inflammatory and fibrinolytic markers in patients undergoing primary elective coronary artery bypass graft with extracorporeal circulation.
Methods: One hundred and thirteen patients (105 males, 8 females) undergoing primary isolated coronary artery bypass with normo- (37 degrees C) or hypothermic (26 degrees C) systemic perfusion were prospectively studied. The clinical course of the patients was recorded and inflammatory and fibrinolytic markers (C-reactive protein, fibrinogen, interleukin-6, plasminogen activator inhibitor-1, prothrombin time, activated partial thromboplastin time, platelets and white blood cell counts) were determined before surgery, 24, 48 and 72 hours thereafter, and at hospital discharge.
Results: Two patients died (mortality 1.7%) and 6 had a major complication (event free survival > 94%). Interleukin-6, lymphocyte, neutrophil and monocyte levels increased after surgery but returned to normal at hospital discharge. C-reactive protein levels increased after 24 hours and remained high at hospital discharge. Plasminogen activator inhibitor-1, prothrombin time, and activated partial thromboplastin time increased from few hours postoperatively and returned to normal before discharge. Platelets decreased immediately after surgery and normalized only at hospital discharge. Fibrinogen decreased in the first 24 postoperative hours, raised later and remained elevated at hospital discharge.
Conclusions: Cardiopulmonary bypass activates inflammatory response and hemostatic/fibrinolytic balance in patients undergoing primary isolated coronary artery bypass.
Similar articles
-
Hemostatic changes and clinical sequelae after on-pump compared with off-pump coronary artery bypass surgery: a prospective randomized study.Coron Artery Dis. 2009 Mar;20(2):100-5. doi: 10.1097/MCA.0b013e3283219e8b. Coron Artery Dis. 2009. PMID: 19293667 Clinical Trial.
-
Thoracic epidural anesthesia decreases C-reactive protein levels in patients undergoing elective coronary artery bypass graft surgery with cardiopulmonary bypass.Minerva Anestesiol. 2008 Nov;74(11):619-26. Minerva Anestesiol. 2008. PMID: 18971890 Clinical Trial.
-
Activation of the coagulation system during coronary artery bypass grafting: comparison between on-pump and off-pump techniques.J Thorac Cardiovasc Surg. 2006 Feb;131(2):290-7. doi: 10.1016/j.jtcvs.2005.10.018. J Thorac Cardiovasc Surg. 2006. PMID: 16434256 Clinical Trial.
-
Release of cardiac biochemical and inflammatory markers in patients on cardiopulmonary bypass undergoing coronary artery bypass grafting.J Card Surg. 2008 Nov-Dec;23(6):681-7. doi: 10.1111/j.1540-8191.2008.00701.x. Epub 2008 Sep 5. J Card Surg. 2008. PMID: 18778302
-
Fat metabolism, the fibrinogen/fibrinolytic system and blood flow: new potentials for the pharmacological treatment of coronary heart disease.Pharmacology. 1981;23(5):271-80. doi: 10.1159/000137560. Pharmacology. 1981. PMID: 7027278 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials